van Leeuwen Caspar M, Oei Arlene L, Chin Kenneth W T K, Crezee Johannes, Bel Arjan, Westermann Anneke M, Buist Marrije R, Franken Nicolaas A P, Stalpers Lukas J A, Kok H Petra
Department of Radiation Oncology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Laboratory for Experimental Oncology and Radiobiology (LEXOR)/Center for Experimental Molecular Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Radiat Oncol. 2017 Apr 27;12(1):75. doi: 10.1186/s13014-017-0813-0.
Combined radiotherapy and hyperthermia is a well-established alternative to chemoradiotherapy for advanced stage cervical cancer patients with a contraindication for chemotherapy. Pre-clinical evidence suggests that the radiosensitizing effect of hyperthermia decreases substantially for time intervals between radiotherapy and hyperthermia as short as 1-2 h, but clinical evidence is limited. The purpose of this study is to determine the effect of the time interval between external beam radiotherapy (EBRT) and same-day hyperthermia on in-field recurrence rate, overall survival and late toxicity in women with advanced stage cervical cancer.
Patients with advanced stage cervical cancer who underwent a full-course of curative daily EBRT and (4-5) weekly hyperthermia sessions between 1999 and 2014 were included for retrospective analysis. The mean time interval between EBRT fractions and same-day hyperthermia was calculated for each patient; the median thereof was used to divide the cohort in a 'short' and 'long' time-interval group. Kaplan-Meier analysis and stepwise Cox regression were used to compare the in-field recurrence and overall survival. Finally, high-grade (≥3) late toxicity was compared across time-interval groups. DNA repair suppression is an important hyperthermia mechanism, DNA damage repair kinetics were therefore studied in patient biopsies to support clinical findings.
Included were 58 patients. The 3-year in field recurrence rate was 18% and 53% in the short (≤79.2 min) and long (>79.2 min) time-interval group, respectively (p = 0.021); the 5-year overall survival was 52% and 17% respectively (p = 0.015). Differences between time-interval groups remained significant for both in-field recurrence (HR = 7.7, p = 0.007) and overall survival (HR = 2.3, p = 0.012) in multivariable Cox regression. No difference in toxicity was observed (p = 1.00), with only 6 and 5 events in the short and long group, respectively. The majority of DNA damage was repaired within 2 h, potentially explaining a reduced effectiveness of hyperthermia for long time intervals.
A short time interval between EBRT and hyperthermia is associated with a lower risk of in-field recurrence and a better overall survival. There was no evidence for difference in late toxicity.
对于有化疗禁忌证的晚期宫颈癌患者,放疗联合热疗是一种成熟的放化疗替代方案。临床前证据表明,放疗与热疗之间的时间间隔短至1 - 2小时,热疗的放射增敏作用就会大幅下降,但临床证据有限。本研究的目的是确定体外放射治疗(EBRT)与当日热疗之间的时间间隔对晚期宫颈癌患者的野内复发率、总生存率和晚期毒性的影响。
纳入1999年至2014年间接受了全疗程根治性每日EBRT及每周(4 - 5)次热疗的晚期宫颈癌患者进行回顾性分析。计算每位患者EBRT分次与当日热疗之间的平均时间间隔;以其中位数将队列分为“短”和“长”时间间隔组。采用Kaplan - Meier分析和逐步Cox回归比较野内复发和总生存率。最后,比较不同时间间隔组的高级别(≥3级)晚期毒性。DNA修复抑制是热疗的重要机制,因此对患者活检组织进行DNA损伤修复动力学研究以支持临床发现。
共纳入58例患者。短(≤79.2分钟)时间间隔组和长(>79.2分钟)时间间隔组的3年野内复发率分别为18%和53%(p = 0.021);5年总生存率分别为52%和17%(p = 0.015)。在多变量Cox回归中,时间间隔组之间在野内复发(HR = 7.7,p = 0.007)和总生存率(HR = 2.3,p = 0.012)方面的差异仍然显著。未观察到毒性差异(p = 1.00),短时间间隔组和长时间间隔组分别仅有6例和5例事件。大部分DNA损伤在2小时内修复,这可能解释了长时间间隔热疗效果降低的原因。
EBRT与热疗之间的短时间间隔与较低的野内复发风险和较好的总生存率相关。没有证据表明晚期毒性存在差异。